SEC Filing Details
Document Details
Form
Filing Date
April 10, 2024
Document Date
April 08, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Kunkel Lori Anne